Hypoglycemia Enhances Epithelial‐Mesenchymal Transition and Invasiveness, and Restrains the Warburg Phenotype, in Hypoxic HeLa Cell Cultures and Microspheroids

The accelerated growth of solid tumors leads to episodes of both hypoxia and hypoglycemia (HH) affecting their intermediary metabolism, signal transduction, and transcriptional activity. A previous study showed that normoxia (20% O2) plus 24 h hypoglycemia (2.5 mM glucose) increased glycolytic flux...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular physiology 2017-06, Vol.232 (6), p.1346-1359
Hauptverfasser: Marín‐Hernández, Álvaro, Gallardo‐Pérez, Juan Carlos, Hernández‐Reséndiz, Ileana, Del Mazo‐Monsalvo, Isis, Robledo‐Cadena, Diana Xochiquetzal, Moreno‐Sánchez, Rafael, Rodríguez‐Enríquez, Sara
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1359
container_issue 6
container_start_page 1346
container_title Journal of cellular physiology
container_volume 232
creator Marín‐Hernández, Álvaro
Gallardo‐Pérez, Juan Carlos
Hernández‐Reséndiz, Ileana
Del Mazo‐Monsalvo, Isis
Robledo‐Cadena, Diana Xochiquetzal
Moreno‐Sánchez, Rafael
Rodríguez‐Enríquez, Sara
description The accelerated growth of solid tumors leads to episodes of both hypoxia and hypoglycemia (HH) affecting their intermediary metabolism, signal transduction, and transcriptional activity. A previous study showed that normoxia (20% O2) plus 24 h hypoglycemia (2.5 mM glucose) increased glycolytic flux whereas oxidative phosphorylation (OxPhos) was unchanged versus normoglycemia in HeLa cells. However, the simultaneous effect of HH on energy metabolism has not been yet examined. Therefore, the effect of hypoxia (0.1–1% O2) plus hypoglycemia on the energy metabolism of HeLa cells was analyzed by evaluating protein content and activity, along with fluxes of both glycolysis and OxPhos. Under hypoxia, in which cell growth ceased and OxPhos enzyme activities, ΔΨm and flux were depressed, hypoglycemia did not stimulate glycolytic flux despite increasing H‐RAS, p‐AMPK, GLUT1, GLUT3, and HKI levels, and further decreasing mitochondrial enzyme content. The impaired mitochondrial function in HH cells correlated with mitophagy activation. The depressed OxPhos and unchanged glycolysis pattern was also observed in quiescent cells from mature multicellular tumor spheroids, suggesting that these inner cell layers are similarly subjected to HH. The principal ATP supplier was glycolysis for HH 2D monolayer and 3D quiescent spheroid cells. Accordingly, the glycolytic inhibitors iodoacetate and gossypol were more effective than mitochondrial inhibitors in decreasing HH‐cancer cell viability. Under HH, stem cell‐, angiogenic‐, and EMT‐biomarkers, as well as glycoprotein‐P content and invasiveness, were also enhanced. These observations indicate that HH cancer cells develop an attenuated Warburg and pronounced EMT‐ and invasive‐phenotype. J. Cell. Physiol. 232: 1346–1359, 2017. © 2016 Wiley Periodicals, Inc. Hypoglycemia enhances (i) epithelial‐mesenchymal transition, (ii) invasiveness, and (iii) restrains the Warburg phenotype in hypoxic HeLa cells.
doi_str_mv 10.1002/jcp.25617
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1904025557</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4316963371</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4477-5952c1513e3be0a83105362c5dd7508e667dce835557ce35209983a947a813133</originalsourceid><addsrcrecordid>eNp9kUFO3DAUhi1EBcPAoheoLLFCImDHcZwsq2jamWoQqAKxjDzOg3jkcVI7oc2OI3AFrsZJcBjKrl1Zsj9_v59_hD5TckYJic_Xqj2LeUrFDppQkosoSXm8iybhjEY5T-g-OvB-TQjJc8b20H4s0kCLdIKe50Pb3JtBwUZLPLO1tAo8nrW6q8FoaV4eny7Ag1X1sJEGXztpve50Y7G0FV7YB-n1A1jw_vRt5yf4zkltPQ4CfCvdqnf3-KoG23RDC6dYWzxm_tEKz2EpcQHG4KI3Xe9C8Ki40Mo1vq3BNbryh-jTnTQejt7XKbr5Nrsu5tHy8vui-LqMVJIIEfGcx4pyyoCtgMiMUcJZGiteVYKTDNJUVAoyxjkXChiPw19kTOaJkBlllLEpOt56W9f86sMU5brpnQ2RJc1JQuLx5n-pTNDwiiTNA3WypcZBvIO7snV6I91QUlKOlZWhsvKtssB-eTf2qw1UH-TfjgJwvgV-awPDv03lj-Jqq3wF3HaheA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1871595469</pqid></control><display><type>article</type><title>Hypoglycemia Enhances Epithelial‐Mesenchymal Transition and Invasiveness, and Restrains the Warburg Phenotype, in Hypoxic HeLa Cell Cultures and Microspheroids</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Marín‐Hernández, Álvaro ; Gallardo‐Pérez, Juan Carlos ; Hernández‐Reséndiz, Ileana ; Del Mazo‐Monsalvo, Isis ; Robledo‐Cadena, Diana Xochiquetzal ; Moreno‐Sánchez, Rafael ; Rodríguez‐Enríquez, Sara</creator><creatorcontrib>Marín‐Hernández, Álvaro ; Gallardo‐Pérez, Juan Carlos ; Hernández‐Reséndiz, Ileana ; Del Mazo‐Monsalvo, Isis ; Robledo‐Cadena, Diana Xochiquetzal ; Moreno‐Sánchez, Rafael ; Rodríguez‐Enríquez, Sara</creatorcontrib><description>The accelerated growth of solid tumors leads to episodes of both hypoxia and hypoglycemia (HH) affecting their intermediary metabolism, signal transduction, and transcriptional activity. A previous study showed that normoxia (20% O2) plus 24 h hypoglycemia (2.5 mM glucose) increased glycolytic flux whereas oxidative phosphorylation (OxPhos) was unchanged versus normoglycemia in HeLa cells. However, the simultaneous effect of HH on energy metabolism has not been yet examined. Therefore, the effect of hypoxia (0.1–1% O2) plus hypoglycemia on the energy metabolism of HeLa cells was analyzed by evaluating protein content and activity, along with fluxes of both glycolysis and OxPhos. Under hypoxia, in which cell growth ceased and OxPhos enzyme activities, ΔΨm and flux were depressed, hypoglycemia did not stimulate glycolytic flux despite increasing H‐RAS, p‐AMPK, GLUT1, GLUT3, and HKI levels, and further decreasing mitochondrial enzyme content. The impaired mitochondrial function in HH cells correlated with mitophagy activation. The depressed OxPhos and unchanged glycolysis pattern was also observed in quiescent cells from mature multicellular tumor spheroids, suggesting that these inner cell layers are similarly subjected to HH. The principal ATP supplier was glycolysis for HH 2D monolayer and 3D quiescent spheroid cells. Accordingly, the glycolytic inhibitors iodoacetate and gossypol were more effective than mitochondrial inhibitors in decreasing HH‐cancer cell viability. Under HH, stem cell‐, angiogenic‐, and EMT‐biomarkers, as well as glycoprotein‐P content and invasiveness, were also enhanced. These observations indicate that HH cancer cells develop an attenuated Warburg and pronounced EMT‐ and invasive‐phenotype. J. Cell. Physiol. 232: 1346–1359, 2017. © 2016 Wiley Periodicals, Inc. Hypoglycemia enhances (i) epithelial‐mesenchymal transition, (ii) invasiveness, and (iii) restrains the Warburg phenotype in hypoxic HeLa cells.</description><identifier>ISSN: 0021-9541</identifier><identifier>EISSN: 1097-4652</identifier><identifier>DOI: 10.1002/jcp.25617</identifier><identifier>PMID: 27661776</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Adenosine Triphosphate - pharmacology ; Angiogenesis ; Antineoplastic Agents - pharmacology ; Attenuation ; Biomarkers ; Biotechnology ; Cancer ; Cell Hypoxia - drug effects ; Cell Proliferation - drug effects ; Cell Survival - drug effects ; Energy metabolism ; Energy Metabolism - drug effects ; Enzymatic activity ; Enzymes ; Epithelial-Mesenchymal Transition - drug effects ; Fluctuations ; Fluxes ; Genotype &amp; phenotype ; Glucose ; Glucose - pharmacology ; Glycolysis ; Glycolysis - drug effects ; Glycoproteins ; Gossypol ; H-Ras protein ; HeLa Cells ; Humans ; Hypoglycemia ; Hypoglycemia - pathology ; Hypoxia ; Inhibitors ; Inhibitory Concentration 50 ; Invasiveness ; MCF-7 Cells ; Mesenchyme ; Metabolism ; Mitochondria ; Mitochondria - drug effects ; Mitochondria - metabolism ; Mitochondrial Degradation - drug effects ; Multicellular tumor spheroids ; Neoplasm Invasiveness ; Oxidative phosphorylation ; Oxygen - pharmacology ; Phenotype ; Phosphorylation ; Signal transduction ; Solid tumors ; Spheroids ; Spheroids, Cellular - drug effects ; Spheroids, Cellular - metabolism ; Spheroids, Cellular - pathology ; Stem cells ; Transcription ; Tumors</subject><ispartof>Journal of cellular physiology, 2017-06, Vol.232 (6), p.1346-1359</ispartof><rights>2016 Wiley Periodicals, Inc.</rights><rights>2017 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4477-5952c1513e3be0a83105362c5dd7508e667dce835557ce35209983a947a813133</citedby><cites>FETCH-LOGICAL-c4477-5952c1513e3be0a83105362c5dd7508e667dce835557ce35209983a947a813133</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjcp.25617$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjcp.25617$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27661776$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marín‐Hernández, Álvaro</creatorcontrib><creatorcontrib>Gallardo‐Pérez, Juan Carlos</creatorcontrib><creatorcontrib>Hernández‐Reséndiz, Ileana</creatorcontrib><creatorcontrib>Del Mazo‐Monsalvo, Isis</creatorcontrib><creatorcontrib>Robledo‐Cadena, Diana Xochiquetzal</creatorcontrib><creatorcontrib>Moreno‐Sánchez, Rafael</creatorcontrib><creatorcontrib>Rodríguez‐Enríquez, Sara</creatorcontrib><title>Hypoglycemia Enhances Epithelial‐Mesenchymal Transition and Invasiveness, and Restrains the Warburg Phenotype, in Hypoxic HeLa Cell Cultures and Microspheroids</title><title>Journal of cellular physiology</title><addtitle>J Cell Physiol</addtitle><description>The accelerated growth of solid tumors leads to episodes of both hypoxia and hypoglycemia (HH) affecting their intermediary metabolism, signal transduction, and transcriptional activity. A previous study showed that normoxia (20% O2) plus 24 h hypoglycemia (2.5 mM glucose) increased glycolytic flux whereas oxidative phosphorylation (OxPhos) was unchanged versus normoglycemia in HeLa cells. However, the simultaneous effect of HH on energy metabolism has not been yet examined. Therefore, the effect of hypoxia (0.1–1% O2) plus hypoglycemia on the energy metabolism of HeLa cells was analyzed by evaluating protein content and activity, along with fluxes of both glycolysis and OxPhos. Under hypoxia, in which cell growth ceased and OxPhos enzyme activities, ΔΨm and flux were depressed, hypoglycemia did not stimulate glycolytic flux despite increasing H‐RAS, p‐AMPK, GLUT1, GLUT3, and HKI levels, and further decreasing mitochondrial enzyme content. The impaired mitochondrial function in HH cells correlated with mitophagy activation. The depressed OxPhos and unchanged glycolysis pattern was also observed in quiescent cells from mature multicellular tumor spheroids, suggesting that these inner cell layers are similarly subjected to HH. The principal ATP supplier was glycolysis for HH 2D monolayer and 3D quiescent spheroid cells. Accordingly, the glycolytic inhibitors iodoacetate and gossypol were more effective than mitochondrial inhibitors in decreasing HH‐cancer cell viability. Under HH, stem cell‐, angiogenic‐, and EMT‐biomarkers, as well as glycoprotein‐P content and invasiveness, were also enhanced. These observations indicate that HH cancer cells develop an attenuated Warburg and pronounced EMT‐ and invasive‐phenotype. J. Cell. Physiol. 232: 1346–1359, 2017. © 2016 Wiley Periodicals, Inc. Hypoglycemia enhances (i) epithelial‐mesenchymal transition, (ii) invasiveness, and (iii) restrains the Warburg phenotype in hypoxic HeLa cells.</description><subject>Adenosine Triphosphate - pharmacology</subject><subject>Angiogenesis</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Attenuation</subject><subject>Biomarkers</subject><subject>Biotechnology</subject><subject>Cancer</subject><subject>Cell Hypoxia - drug effects</subject><subject>Cell Proliferation - drug effects</subject><subject>Cell Survival - drug effects</subject><subject>Energy metabolism</subject><subject>Energy Metabolism - drug effects</subject><subject>Enzymatic activity</subject><subject>Enzymes</subject><subject>Epithelial-Mesenchymal Transition - drug effects</subject><subject>Fluctuations</subject><subject>Fluxes</subject><subject>Genotype &amp; phenotype</subject><subject>Glucose</subject><subject>Glucose - pharmacology</subject><subject>Glycolysis</subject><subject>Glycolysis - drug effects</subject><subject>Glycoproteins</subject><subject>Gossypol</subject><subject>H-Ras protein</subject><subject>HeLa Cells</subject><subject>Humans</subject><subject>Hypoglycemia</subject><subject>Hypoglycemia - pathology</subject><subject>Hypoxia</subject><subject>Inhibitors</subject><subject>Inhibitory Concentration 50</subject><subject>Invasiveness</subject><subject>MCF-7 Cells</subject><subject>Mesenchyme</subject><subject>Metabolism</subject><subject>Mitochondria</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - metabolism</subject><subject>Mitochondrial Degradation - drug effects</subject><subject>Multicellular tumor spheroids</subject><subject>Neoplasm Invasiveness</subject><subject>Oxidative phosphorylation</subject><subject>Oxygen - pharmacology</subject><subject>Phenotype</subject><subject>Phosphorylation</subject><subject>Signal transduction</subject><subject>Solid tumors</subject><subject>Spheroids</subject><subject>Spheroids, Cellular - drug effects</subject><subject>Spheroids, Cellular - metabolism</subject><subject>Spheroids, Cellular - pathology</subject><subject>Stem cells</subject><subject>Transcription</subject><subject>Tumors</subject><issn>0021-9541</issn><issn>1097-4652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFO3DAUhi1EBcPAoheoLLFCImDHcZwsq2jamWoQqAKxjDzOg3jkcVI7oc2OI3AFrsZJcBjKrl1Zsj9_v59_hD5TckYJic_Xqj2LeUrFDppQkosoSXm8iybhjEY5T-g-OvB-TQjJc8b20H4s0kCLdIKe50Pb3JtBwUZLPLO1tAo8nrW6q8FoaV4eny7Ag1X1sJEGXztpve50Y7G0FV7YB-n1A1jw_vRt5yf4zkltPQ4CfCvdqnf3-KoG23RDC6dYWzxm_tEKz2EpcQHG4KI3Xe9C8Ki40Mo1vq3BNbryh-jTnTQejt7XKbr5Nrsu5tHy8vui-LqMVJIIEfGcx4pyyoCtgMiMUcJZGiteVYKTDNJUVAoyxjkXChiPw19kTOaJkBlllLEpOt56W9f86sMU5brpnQ2RJc1JQuLx5n-pTNDwiiTNA3WypcZBvIO7snV6I91QUlKOlZWhsvKtssB-eTf2qw1UH-TfjgJwvgV-awPDv03lj-Jqq3wF3HaheA</recordid><startdate>201706</startdate><enddate>201706</enddate><creator>Marín‐Hernández, Álvaro</creator><creator>Gallardo‐Pérez, Juan Carlos</creator><creator>Hernández‐Reséndiz, Ileana</creator><creator>Del Mazo‐Monsalvo, Isis</creator><creator>Robledo‐Cadena, Diana Xochiquetzal</creator><creator>Moreno‐Sánchez, Rafael</creator><creator>Rodríguez‐Enríquez, Sara</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>201706</creationdate><title>Hypoglycemia Enhances Epithelial‐Mesenchymal Transition and Invasiveness, and Restrains the Warburg Phenotype, in Hypoxic HeLa Cell Cultures and Microspheroids</title><author>Marín‐Hernández, Álvaro ; Gallardo‐Pérez, Juan Carlos ; Hernández‐Reséndiz, Ileana ; Del Mazo‐Monsalvo, Isis ; Robledo‐Cadena, Diana Xochiquetzal ; Moreno‐Sánchez, Rafael ; Rodríguez‐Enríquez, Sara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4477-5952c1513e3be0a83105362c5dd7508e667dce835557ce35209983a947a813133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adenosine Triphosphate - pharmacology</topic><topic>Angiogenesis</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Attenuation</topic><topic>Biomarkers</topic><topic>Biotechnology</topic><topic>Cancer</topic><topic>Cell Hypoxia - drug effects</topic><topic>Cell Proliferation - drug effects</topic><topic>Cell Survival - drug effects</topic><topic>Energy metabolism</topic><topic>Energy Metabolism - drug effects</topic><topic>Enzymatic activity</topic><topic>Enzymes</topic><topic>Epithelial-Mesenchymal Transition - drug effects</topic><topic>Fluctuations</topic><topic>Fluxes</topic><topic>Genotype &amp; phenotype</topic><topic>Glucose</topic><topic>Glucose - pharmacology</topic><topic>Glycolysis</topic><topic>Glycolysis - drug effects</topic><topic>Glycoproteins</topic><topic>Gossypol</topic><topic>H-Ras protein</topic><topic>HeLa Cells</topic><topic>Humans</topic><topic>Hypoglycemia</topic><topic>Hypoglycemia - pathology</topic><topic>Hypoxia</topic><topic>Inhibitors</topic><topic>Inhibitory Concentration 50</topic><topic>Invasiveness</topic><topic>MCF-7 Cells</topic><topic>Mesenchyme</topic><topic>Metabolism</topic><topic>Mitochondria</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - metabolism</topic><topic>Mitochondrial Degradation - drug effects</topic><topic>Multicellular tumor spheroids</topic><topic>Neoplasm Invasiveness</topic><topic>Oxidative phosphorylation</topic><topic>Oxygen - pharmacology</topic><topic>Phenotype</topic><topic>Phosphorylation</topic><topic>Signal transduction</topic><topic>Solid tumors</topic><topic>Spheroids</topic><topic>Spheroids, Cellular - drug effects</topic><topic>Spheroids, Cellular - metabolism</topic><topic>Spheroids, Cellular - pathology</topic><topic>Stem cells</topic><topic>Transcription</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marín‐Hernández, Álvaro</creatorcontrib><creatorcontrib>Gallardo‐Pérez, Juan Carlos</creatorcontrib><creatorcontrib>Hernández‐Reséndiz, Ileana</creatorcontrib><creatorcontrib>Del Mazo‐Monsalvo, Isis</creatorcontrib><creatorcontrib>Robledo‐Cadena, Diana Xochiquetzal</creatorcontrib><creatorcontrib>Moreno‐Sánchez, Rafael</creatorcontrib><creatorcontrib>Rodríguez‐Enríquez, Sara</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Journal of cellular physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marín‐Hernández, Álvaro</au><au>Gallardo‐Pérez, Juan Carlos</au><au>Hernández‐Reséndiz, Ileana</au><au>Del Mazo‐Monsalvo, Isis</au><au>Robledo‐Cadena, Diana Xochiquetzal</au><au>Moreno‐Sánchez, Rafael</au><au>Rodríguez‐Enríquez, Sara</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypoglycemia Enhances Epithelial‐Mesenchymal Transition and Invasiveness, and Restrains the Warburg Phenotype, in Hypoxic HeLa Cell Cultures and Microspheroids</atitle><jtitle>Journal of cellular physiology</jtitle><addtitle>J Cell Physiol</addtitle><date>2017-06</date><risdate>2017</risdate><volume>232</volume><issue>6</issue><spage>1346</spage><epage>1359</epage><pages>1346-1359</pages><issn>0021-9541</issn><eissn>1097-4652</eissn><abstract>The accelerated growth of solid tumors leads to episodes of both hypoxia and hypoglycemia (HH) affecting their intermediary metabolism, signal transduction, and transcriptional activity. A previous study showed that normoxia (20% O2) plus 24 h hypoglycemia (2.5 mM glucose) increased glycolytic flux whereas oxidative phosphorylation (OxPhos) was unchanged versus normoglycemia in HeLa cells. However, the simultaneous effect of HH on energy metabolism has not been yet examined. Therefore, the effect of hypoxia (0.1–1% O2) plus hypoglycemia on the energy metabolism of HeLa cells was analyzed by evaluating protein content and activity, along with fluxes of both glycolysis and OxPhos. Under hypoxia, in which cell growth ceased and OxPhos enzyme activities, ΔΨm and flux were depressed, hypoglycemia did not stimulate glycolytic flux despite increasing H‐RAS, p‐AMPK, GLUT1, GLUT3, and HKI levels, and further decreasing mitochondrial enzyme content. The impaired mitochondrial function in HH cells correlated with mitophagy activation. The depressed OxPhos and unchanged glycolysis pattern was also observed in quiescent cells from mature multicellular tumor spheroids, suggesting that these inner cell layers are similarly subjected to HH. The principal ATP supplier was glycolysis for HH 2D monolayer and 3D quiescent spheroid cells. Accordingly, the glycolytic inhibitors iodoacetate and gossypol were more effective than mitochondrial inhibitors in decreasing HH‐cancer cell viability. Under HH, stem cell‐, angiogenic‐, and EMT‐biomarkers, as well as glycoprotein‐P content and invasiveness, were also enhanced. These observations indicate that HH cancer cells develop an attenuated Warburg and pronounced EMT‐ and invasive‐phenotype. J. Cell. Physiol. 232: 1346–1359, 2017. © 2016 Wiley Periodicals, Inc. Hypoglycemia enhances (i) epithelial‐mesenchymal transition, (ii) invasiveness, and (iii) restrains the Warburg phenotype in hypoxic HeLa cells.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>27661776</pmid><doi>10.1002/jcp.25617</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0021-9541
ispartof Journal of cellular physiology, 2017-06, Vol.232 (6), p.1346-1359
issn 0021-9541
1097-4652
language eng
recordid cdi_proquest_journals_1904025557
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adenosine Triphosphate - pharmacology
Angiogenesis
Antineoplastic Agents - pharmacology
Attenuation
Biomarkers
Biotechnology
Cancer
Cell Hypoxia - drug effects
Cell Proliferation - drug effects
Cell Survival - drug effects
Energy metabolism
Energy Metabolism - drug effects
Enzymatic activity
Enzymes
Epithelial-Mesenchymal Transition - drug effects
Fluctuations
Fluxes
Genotype & phenotype
Glucose
Glucose - pharmacology
Glycolysis
Glycolysis - drug effects
Glycoproteins
Gossypol
H-Ras protein
HeLa Cells
Humans
Hypoglycemia
Hypoglycemia - pathology
Hypoxia
Inhibitors
Inhibitory Concentration 50
Invasiveness
MCF-7 Cells
Mesenchyme
Metabolism
Mitochondria
Mitochondria - drug effects
Mitochondria - metabolism
Mitochondrial Degradation - drug effects
Multicellular tumor spheroids
Neoplasm Invasiveness
Oxidative phosphorylation
Oxygen - pharmacology
Phenotype
Phosphorylation
Signal transduction
Solid tumors
Spheroids
Spheroids, Cellular - drug effects
Spheroids, Cellular - metabolism
Spheroids, Cellular - pathology
Stem cells
Transcription
Tumors
title Hypoglycemia Enhances Epithelial‐Mesenchymal Transition and Invasiveness, and Restrains the Warburg Phenotype, in Hypoxic HeLa Cell Cultures and Microspheroids
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T17%3A00%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypoglycemia%20Enhances%20Epithelial%E2%80%90Mesenchymal%20Transition%20and%20Invasiveness,%20and%20Restrains%20the%20Warburg%20Phenotype,%20in%20Hypoxic%20HeLa%20Cell%20Cultures%20and%20Microspheroids&rft.jtitle=Journal%20of%20cellular%20physiology&rft.au=Mar%C3%ADn%E2%80%90Hern%C3%A1ndez,%20%C3%81lvaro&rft.date=2017-06&rft.volume=232&rft.issue=6&rft.spage=1346&rft.epage=1359&rft.pages=1346-1359&rft.issn=0021-9541&rft.eissn=1097-4652&rft_id=info:doi/10.1002/jcp.25617&rft_dat=%3Cproquest_cross%3E4316963371%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1871595469&rft_id=info:pmid/27661776&rfr_iscdi=true